Differential Analysis of Expressed Genes in Diabetic Nephropathy Based on Bioinformatics Technology

Objective: Bioinformatics technology was used in this study to analyze the expression data of patients with diabetic nephropathy (DN) and normal subjects from the microarray. The purpose of this study was to screen the differentially expressed genes in DN and to explore the pathogenesis and potential therapeutic targets of DN. Methods: : The data of gene expression in the gse142153 gene chip was downloaded from the gene expression database (GEO). The up-regulated and down-regulated expressed genes were analyzed by R language. The core genes of differentially expressed genes were analyzed by string database, Cytoscape software and its plug-in. The differentially expressed genes were analyzed by gene ontology and Kyoto Encyclopedia of genes and genomes. Results: : A total of 112 differentially expressed genes were screened, including 50 down-regulated genes and 62 up-regulated genes. There are 10 up-regulated core genes including CXCL8, MMP9, IL1B, IL6, IL10, CXCL2, CCL20, ATF3, CXCL3, F3. Their biological effects are mainly concentrated in the IL-17 signaling pathway, rheumatoid arthritis, viral protein interaction with cytokine and cytokine receptor, Amoebiasis, TNF signaling pathway, Legionellosis, Cytokine-cytokine receptor interaction, Lipid, and atherosclerosis, Malaria, NOD-like receptor signaling pathway, etc. Conclusion: Analysis of differentially expressed genes and core genes enhanced the understanding of the pathogenesis of DN and provided a potential train of thought for the treatment of DN.